BREATHE Trademark

Trademark Overview


On Monday, September 11, 2023, a trademark application was filed for BREATHE with the United States Patent and Trademark Office. The USPTO has given the BREATHE trademark a serial number of 98174460. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, May 13, 2024. This trademark is owned by Keystone Orthotropix LLC. The BREATHE trademark is filed in the Medical Instrument Products category with the following description:

oral contact devices engineered to develop and support an infant's airway and facial growth, including bottles, cups, pacifiers, and the like
breathe

General Information


Serial Number98174460
Word MarkBREATHE
Filing DateMonday, September 11, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesoral contact devices engineered to develop and support an infant's airway and facial growth, including bottles, cups, pacifiers, and the like

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, October 2, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKeystone Orthotropix LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhoenix, AZ 85022

Trademark Events


Event DateEvent Description
Monday, October 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 14, 2023NEW APPLICATION ENTERED
Monday, May 13, 2024NON-FINAL ACTION E-MAILED
Monday, May 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2024ASSIGNED TO EXAMINER
Monday, May 13, 2024NON-FINAL ACTION WRITTEN